GOBER ET AL.
9 of 11
4
|
MATERIALS AND METHODS
| Materials
15.4 mmol/2.3 eq, 5.7 mmol). All reactions were performed at room
temperature. For Fmoc removal, 20% (v/v) piperidine in DMF was
used. Cleavage of the peptidyl-resin to obtain crude peptides was
performed using TFA/TIS/water/EDT (92.5:2.5:2.5:2.5 v/v). Crude
peptides were analyzed by reversed-phase UHPLC (Waters Acquity
HSS T3 100 Å, 1.8 μm, 2.1 × 150 mm) using a linear gradient of 0.1%
TFA in acetonitrile. Peptides were purified by preparative reversed-
phase HPLC using Luna ® C18(3) 10-μm particle size media packed in
an axial compression column (ModCol ®, 25 × 5 iD). After purification,
the peptides were lyophilized to give white powders. No correction
for TFA and water content was performed prior to weighing out
peptides for the maleimide conjugation experiments.
4.1
MHH was purchased from AldLab (Woburn, MA), and PEGMA10K
was purchased from JenKem Technology USA (Plano, TX).
Dimethylformamide was purchased from Univar Solutions Inc.
(Downers Grove, IL). N,N-diisopropylethylamine was purchased from
Spectrum Laboratory Products Inc. (Gardena, CA). Piperidine was pur-
chased from Tedia Company Inc. (Fairfield, OH). Isopropyl alcohol was
purchased from Brenntag Pacific Inc. (Santa Fe Springs, CA).
Diisopropyl ether was purchased from Neuchem (Sparks, NV).
N,N0-diisopropylcarbodiimide, triisopropylsilane, 1,2-ethanedithiol,
potassium phosphate monobasic, and potassium phosphate dibasic
were purchased from Sigma-Aldrich (St. Louis, MO). HPLC grade
trifluoroacetic acid was purchased from Alfa Aesar (Haverhill, MA).
HPLC grade water and acetonitrile were obtained from
MilliporeSigma (Burlington, MA). All other amino acid derivatives and
reagents were obtained from Bachem AG, Bubendorf, Switzerland.
Preparative HPLC purification was performed using a Waters
Prep LC system. HPLC and UHPLC analyses were performed on a
Thermo Scientific UltiMate 3000 UHPLC system using an Atlantis T3
100 Å, 3 μm, 4.6 mm × 150-mm column and a Waters Acquity HSS
T3 100 Å, 1.8 μm, 2.1 × 150 mm column, respectively. A Thermo Sci-
entific Vanquish UHPLC system with a Waters Acquity CSH C18
130 Å, 1.7 μm, 2.1-mm × 150-mm column was used for UHPLC–MS
separations. MS analysis was performed in positive ion mode on a
Thermo Scientific Q Exactive Focus Hybrid Quadrupole-Orbtitrap™
mass spectrometer. For MS/MS analyses, high-energy C-trap dissocia-
tion (HCD) was used for fragmentation.
4.3
|
Maleimide conjugation time course
experiments
4.3.1
|
MPA
A solution of MPA (2 mg/ml) and a solution of CXF peptide (2 mg/ml)
were prepared separately in aqueous 0.1-M potassium phosphate
solution in 10:90 acetonitrile: water (for CLF-MPA conjugation, the
peptide and MPA were dissolved in 0.1-M potassium phosphate
solution containing 26:74 acetonitrile: water to help solubilize the
peptide). Reactions were initiated by mixing the solution of MPA with
the solution of CXF. The reaction was performed in a sealed microce-
ntrifuge tube at ambient temperature. An aliquot of the reaction
solution was removed at the appropriate time point and was
quenched using an equal volume of a solution of 1% TFA in water.
The apparent pH of the solutions used during the CXF and
maleimide conjugations was measured using a Mettler Toledo™
SevenCompact™ S220-Basic pH/ion benchtop meter equipped with a
Mettler Toledo™ InLab Solids Go-ISM® electrode (pH 1–11; 0–80ꢀC).
The electrode was calibrated before each series of measurements
using standard buffer solutions purchased from Millipore Sigma
(Burlington, MA). All measurements were taken at ambient
temperature.
4.3.2
|
MHH
A solution of MHH (2 mg/ml) was dissolved in 50% acetonitrile in
water, and a solution of CXF peptide (2 mg/ml) was prepared in aque-
ous 0.1-M potassium phosphate solution in 10:90 acetonitrile: water
(for CLF-MPA conjugation, the peptide and MHH were dissolved in
0.1-M potassium phosphate solution containing 28:72 acetonitrile in
water). Reactions were initiated by mixing the solution of MPA with
the solution of CXF. The reaction was performed in a sealed microce-
ntrifuge tube at ambient temperature. An aliquot of the reaction
solution was removed at the appropriate time point and was
quenched using an equal volume of a solution of 1% TFA in water.
4.2
|
Manual Fmoc solid-phase peptide synthesis
The peptides H-Cys-Gly-Phe-OH (CGF), H-Cys-Leu-Phe-OH (CLF),
H-Cys-Glu-Phe-OH (CEF), H-Cys-Lys-Phe-OH (CKF), and H-Cys-Ser-
Phe-OH (CSF) were synthesized on a 2.5-mmol scale by first loading
Fmoc-Phe-OH onto 2-chlorotrityl chloride resin (10-mmol scale,
substitution = 1.3 mmol/g) and then splitting the resin into four lots
for the subsequent divergent coupling reactions. Loading of the first
amino acid derivative was carried out using Fmoc-Phe-OH (1.0 eq.,
10 mmol) and DIPEA (1.0 eq., 10 mmol) in dimethylformamide (DMF).
Coupling of the second amino acid derivative was performed using
TCTU/DIPEA (1.9 eq., 4.8 mmol/2.5 eq., 6.3 mmol) in DMF. Coupling
of Fmoc-Cys (Trt)-OH was performed using DIC/HOBt (6.2 eq,
4.3.3
|
PEGMA10K
A solution of PEGMA10K (25 mg/ml) and CXF peptide (1.55 mg/ml)
was dissolved in unbuffered water with 10% acetonitrile. The solu-
tions of peptide and maleimide were mixed and allowed to react for
1 h. After 1 h, another portion of PEGMA10K (22 mg/ml) in
unbuffered water with 10% acetonitrile was added. The reaction was
allowed to proceed for another hour before the pH was adjusted to